Jentashapir Journal of Health Research

Published by: Kowsar

Association Between Retroperitoneal Lymphadenectomy and Survival Benefit in the Endometrioid-Type Endometrial Carcinoma Patients

Fatemeh Cheraghi 1 , * , Mitra Modaress Gilani 2 , Fatemeh Ghaemmaghami 2 and Azamsadat Mousavi 2
Authors Information
1 Fertility, Infertility and Perinatology Research Center, Imam Khomeini Hospital, Medical Faculty, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Vali-e-Asr Hospital, Medical Faculty, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Jentashapir Journal of Health Research: June 2015, 6 (3); e28713
  • Published Online: June 27, 2015
  • Article Type: Research Article
  • Received: June 18, 2014
  • Accepted: December 26, 2014
  • DOI: 10.5812/jjhr.28713v2

To Cite: Cheraghi F, Modaress Gilani M, Ghaemmaghami F, Mousavi A. Association Between Retroperitoneal Lymphadenectomy and Survival Benefit in the Endometrioid-Type Endometrial Carcinoma Patients, Jundishapur J Helath Res. 2015 ;6(3):e28713. doi: 10.5812/jjhr.28713v2.

Abstract
Copyright: Copyright © 0, Jentashapir Journal of Health Research. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58(2): 71-96[DOI][PubMed]
  • 2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006; 56(2): 106-30[PubMed]
  • 3. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987; 60(8 Suppl): 2035-41[PubMed]
  • 4. Creasman WT. Announcement. FIGO stages–1988 Revisions. Gynecol Oncol. 1989; 35: 125-7
  • 5. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, et al. Uterine cancers. J Natl Compr Canc Netw. 2006; 4(5): 438-62[PubMed]
  • 6. American College of O. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol. 2005; 106(2): 413-25[PubMed]
  • 7. Kitchener H, Redman CW, Swart AM, Amos CL. on behalf of ASTEC Study Group. ASTEC. A study in the treatment of endometrial cancer. A randomised trial of lymphadenectomy in the treatment of endometrial cancer. Gynecol Oncol. 2006; 101
  • 8. Huh WK, Straughn JJ, Kelly FJ, Kilgore LC. Endometrial carcinoma. Curr Treat Options Oncol. 2001; 2(2): 129-35[PubMed]
  • 9. Aalders JG, Thomas G. Endometrial cancer--revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol. 2007; 104(1): 222-31[DOI][PubMed]
  • 10. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F3, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol. 1995; 56(1): 29-33[DOI][PubMed]
  • 11. Mohan DS, Samuels MA, Selim MA, Shalodi AD, Ellis RJ, Samuels JR, et al. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol. 1998; 70(2): 165-71[DOI][PubMed]
  • 12. Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005; 23(16): 3668-75[DOI][PubMed]
  • 13. Trimble EL, Kosary C, Park RC. Lymph node sampling and survival in endometrial cancer. Gynecol Oncol. 1998; 71(3): 340-3[DOI][PubMed]
  • 14. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000; 182(6): 1506-19[DOI][PubMed]
  • 15. Carey MS, O'Connell GJ, Johanson CR, Goodyear MD, Murphy KJ, Daya DM, et al. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol. 1995; 57(2): 138-44[DOI][PubMed]
  • 16. Eltabbakh GH, Piver MS, Hempling RE, Shin KH. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys. 1997; 38(2): 373-80[PubMed]
  • 17. Chan JK, Wu H, Cheung MK, Shin JY, Osann K, Kapp DS. The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol. 2007; 106(2): 282-8[DOI][PubMed]
  • 18. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer. 2006; 107(8): 1823-30[DOI][PubMed]
  • 19. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004; 92(3): 744-51[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader